Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding

IUBMB Life

Volumn 63, Issue 4, 2011, Pages 277-285

  Kaneko, Kenichi ^a   Chuang, Victor Tuan Giam ^a,b,c   Minomo, Ai ^a   Yamasaki, Keishi ^b   Bhagavan, Nadhipuram V ^d   Maruyama, Toru ^a   Otagiri, Masaki ^a,b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SOJO UNIVERSITY   (Japan)

^c CURTIN UNIVERSITY   (Australia)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

allosteric ligand binding; histidine; human serum albumin; N B transition; photoaffinity labeling

Indexed keywords

CYANOGEN BROMIDE; HISTIDINE 105; HISTIDINE 128; HISTIDINE 146; HISTIDINE 39; HISTIDINE 67; HISTIDINE 9; HUMAN SERUM ALBUMIN; IMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; HUMAN; LIGAND BINDING; MUTATION; PH; PHOTOAFFINITY LABELING; ULTRAFILTRATION;

EID: 79954543452     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.457     Document Type: Article

References (36)

1. Peters, T., (1996) All about Albumin: Biochemistry, Genetics, and Medical Applications. Academic Press, San Diego.
2. Kragh-Hansen, U., (1990) Structure and ligand binding properties of human serum albumin. Dan. Med. Bull. 37, 57-84.
3. Kragh-Hansen U., Chuang V. T., and, Otagiri, M., (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol. Pharm. Bull. 25, 695-704. (Pubitemid 40036701)
4. Sudlow G., Birkett, D. J., and, Wade, D. N., (1975) The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11, 824-832.
5. Sudlow, G., Birkett, D. J., and, Wade, D. N., (1976) Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 12, 1052-1061.
6. Curry, S., Brick, P., and, Franks, N. P., (1999) Fatty acid binding to human serum albumin: new insights from crystallographic studies. Biochim. Biophys. Acta 1441, 131-140. (Pubitemid 29537733)
7. Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., and, Curry, S., (2001) Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site, I. J. Biol. Chem. 276, 22804-22809.
8. Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., and, Curry, S., (2005) Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353, 38-52. (Pubitemid 41338838)
9. Chuang, V. T., and, Otagiri, M., (2002) How do fatty acids cause allosteric binding of drugs to human serum albumin? Pharm. Res. 19, 1458-1464. (Pubitemid 35266549)
10. Yamasaki, K., Rahman, M. H., Tsutsumi, Y., Maruyama, T., Ahmed, S., Kragh-Hansen, U., and, Otagiri, M., (2000) Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen. AAPS PharmSciTech. 1, 45-54.
11. Sakai, T., Yamasaki, K., Sako, T., Kragh-Hansen, U., Suenaga, A., and, Otagiri, M., (2001) Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharm. Res. 18, 520-524. (Pubitemid 32592585)
12. Yamasaki, K., Maruyama, T., Yoshimoto, K., Tsutsumi, Y., Narazaki, R., Fukuhara, A., Kragh-Hansen, U., and, Otagiri, M., (1999) Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. Biochim. Biophys. Acta 1432, 313-323. (Pubitemid 29304539)
13. Era, S., Itoh, K. B., Sogami, M., Kuwata, K., Iwama, T., Yamada, H., and, Watari, H., (1990) Structural transition of bovine plasma albumin in the alkaline region - the N-B transition. Int. J. Pept. Protein Res. 35, 1-11.
14. Bos, O. J., Labro, J. F., Fischer, M. J., Wilting, J., and, Janssen, L. H., (1989) The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin. J. Biol. Chem. 264, 953-959. (Pubitemid 19038078)
15. Janssen, L. H., Van Wilgenburg, M. T., and, Wilting, J., (1981) Human serum albumin as an allosteric two-state protein. Evidence from effects of calcium and warfarin on proton binding behaviour. Biochim. Biophys. Acta 669, 244-250. (Pubitemid 11001702)
16. Janssen, L. H., Dröge, J. H., Durlinger, F. C., and, Fruytier, F. J., (1985) The pH dependence of the thermodynamics of the interaction of diazepam with human serum albumin. J. Biol. Chem. 260, 11442-11445. (Pubitemid 16252134)
17. Dröge, J. H., Janssen, L. H., and, Wilting, J., (1983) Allosteric properties of the oxyphenbutazone - human serum albumin complex. Pharm. Weekbl. Sci. 5, 228-233. (Pubitemid 14237595)
18. Dröge, J. H., Wilting, J., and, Janssen, L. H., (1982) A comparative study of some physico-chemical properties of human serum albumin samples from different sources - II. The characteristics of the N-B transition and the binding behaviour with regard to warfarin and diazepam. Biochem. Pharmacol. 31, 3781-3786. (Pubitemid 13218451)
19. Dröge, J. H., Janssen, L. H., and, Wilting, J., (1985) A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry. Biochim. Biophys. Acta 827, 396-402. (Pubitemid 15143626)
20. Rietbrock, N., Menke, G., Reuter, G., Lassmann, A., and, Schmeidl, R., (1985) Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies. J. Clin. Chem. Clin. Biochem. 23, 719-723. (Pubitemid 16208262)
21. Soltys, B. J., and, Hsia, J. C., (1977) Fatty acid enhancement of human serum albumin binding properties. A spin label study. J. Biol. Chem. 252, 4043-4048. (Pubitemid 8114422)
22. Hsia, J. C., and, Kwan, N. H., (1981) Human serum albumin: binding specificity and allosteric effect of parinarate and stearate. A dianionic spin label study. J. Biol. Chem. 256, 2242-2244.
23. Menke, G., Wörner, W., Kratzer, W., and, Rietbrock, N., (1989) Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths. N-S. Arch. Pharmacol. 339, 42-47. (Pubitemid 19074397)
24. Bhattacharya, A. A., Grune, T., and, Curry, S., (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303, 721-732.
25. Fanali, G., Fesce, R., Agrati, C., Ascenzi, P., and, Fasano, M., (2005) Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization. FEBS J. 272, 4672-4683. (Pubitemid 41366990)
26. Galantini, L., Leggio, C., Konarev, P. V., and, Pavel, N. V., (2010) Human serum albumin binding ibuprofen: a 3D description of the unfolding pathway in urea. Biophys. Chem. 147, 111-122.
27. Bos, O. J., Vansterkenburg, E. L., Boon, J. P., Fischer, M. J., Wilting, J., and, Janssen, L. H., (1990) Location and characterization of the suramin binding sites of human serum albumin. Biochem. Pharmacol. 40, 1595-1599. (Pubitemid 20310579)
28. Kosa, T., Maruyama, T., Sakai, N., Yonemura, N., Yahara, S., and, Otagiri, M., (1998) Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions. Pharm. Res. 15, 592-598. (Pubitemid 28214953)
29. Yang, J., Ha, C. E., and, Bhagavan, N. V., (2005) Site-directed mutagenesis study of the role of histidine residues in the neutral-to-basic transition of human serum albumin. Biochim. Biophys. Acta 1724, 37-48. (Pubitemid 40799109)
30. Watanabe, H., Kragh-Hansen, U., Tanase, S., Nakajou, K., Mitarai, M., Iwao, Y., Maruyama, T., and, Otagiri, M., (2001) Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem. J. 357, 269-274. (Pubitemid 32642926)
31. Kaneko, K., Fukuda, H., Chuang, V. T., Yamasaki, K., Kawahara, K., Nakayama, H., Suenaga, A., Maruyama, T., and, Otagiri, M., (2008) Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin. Drug Metab. Dispos. 36, 81-86.
32. Chuang, V. T., Kuniyasu, A., Nakayama, H., Matsushita, Y., Hirono, S., and, Otagiri, M., (1999) Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety. Biochim. Biophys. Acta 1434, 18-30. (Pubitemid 29521329)
33. Salaman, M. R., and, Warwicker, J., (2005) Anomalies in the ionic properties of serum albumin. Proteins 61, 468-472. (Pubitemid 41547402)
34. Rahman, M. H., Maruyama, T., Okada, T., Yamasaki, K., and, Otagiri, M., (1993) Study of interaction of carprofen and its enantiomers with human serum albumin - I. Mechanism of binding studied by dialysis and spectroscopic methods. Biochem. Pharmacol. 46, 1721-1731. (Pubitemid 23349019)
35. Maruyama, T., Lin, C. C., Yamasaki, K., Miyoshi, T., Imai, T., Yamasaki, M., and, Otagiri, M., (1993) Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group. Biochem. Pharmacol. 45, 1017-1026. (Pubitemid 23079978)
36. Wanwimolruk, S., and, Birkett, D. J., (1982) The effects of N-B transition of human serum albumin on the specific drug-binding sites. Biochim. Biophys. Acta 709, 247-255. (Pubitemid 13156030)